miR-216b-5p对喉癌TU686细胞增殖、迁移和侵袭的影响及其机制

doi:10.13481/j.1671-587X.20230115

摘要/Abstract

摘要：

目的探讨miR-216b-5p对喉鳞状细胞癌（LSCC）TU686细胞增殖、迁移、侵袭和凋亡的影响，分析其在喉癌细胞中的靶基因及其可能的作用机制。方法 TU686细胞分为对照组和miR-216b-5p组，对照组细胞通过慢病毒感染无义序列，miR-216b-5p组细胞通过慢病毒感染过表达miR-216b-5p。采用实时荧光定量PCR（RT-qPCR）法检测2组细胞中miR-216b-5p表达水平，克隆形成实验检测2组细胞克隆形成率，细胞划痕实验检测2组细胞划痕愈合率，Transwell实验检测2组细胞中侵袭细胞数，流式细胞术检测2组细胞凋亡率。通过TargetScan网站预测miR-216b-5p的潜在靶基因，采用RT-qPCR法检测靶基因mRNA表达水平，双荧光素酶报告基因实验检测miR-216b-5p与靶基因间的靶向关系。结果慢病毒感染后，与对照组比较，miR-216b-5p组细胞中miR-216b-5p表达水平明显升高（P<0.01）。与对照组比较，miR-216b-5p组细胞克隆形成率和划痕愈合率明显降低（P<0.01），侵袭细胞数明显减少（P<0.01），细胞凋亡率明显升高（P<0.01）。TargetScan网站预测，自噬相关基因5（ATG5）为miR-216b-5p潜在的靶基因，与对照组比较，miR-216b-5p组细胞中ATG5 mRNA表达水平明显降低（P<0.01）。双荧光素酶报告基因实验证实ATG5与miR-216b-5p之间存在靶向关系。结论 miR-216b-5p通过抑制喉癌细胞的增殖、迁移、侵袭和诱导细胞凋亡进而发挥抑癌作用，其机制可能与靶向调节ATG5的表达水平有关。

关键词: 喉肿瘤, 喉鳞状细胞癌, miR-216b-5p, TU686细胞, 自噬相关基因5

Abstract:

Objective To investigate the effect of miR-216b-5p on the proliferation， migration，invasion and apoptosis of laryngeal squamous cell cancer（LSCC） TU686 cells，and to analyze the target genes in laryngeal cancer cells and its possible mechanism. Methods The TU686 cells were divided into control group and miR-216b-5p group；the cells in control group were infected with the nonsense sequence through lentivirus，and the cells in miR-216b-5p group were infected with overexpressed miR-216b-5p by lentivirus.The expression levels of miR-216b-5p in the cells in two groups were detected by real-time fluorescence quantitative PCR（RT-qPCR） method， the clone formation rates of the cells in two groups were detected by clone formation assay，the scratch healing rates of cells in two groups were detected by cell scratch assay，the number of invasion cells in two groups was detected by Transwell assay，and the apoptotic rates of cells in two groups were detected by flow cytometry. The TargetScan website was used to predict the potential target genes of miR-216b-5p. The expression levels of target gene mRNA were detected by RT-qPCR method.The targeting relationship between miR-216b-5p and the target gene was detected by dual-luciferase assay. Results After lentivirus infection， compared with control group， the expression level of miR-216b-5p in the cells in miR-216b-5p group was significantly increased（P<0.01）.Compared with control group，the clone formation rate and the scratch healing rate of the cells in miR-216b-5p group were significantly decreased（P<0.01），the number of invasion cells was significantly decreased（P<0.01）， and the apoptotic rate was significantly increased（P<0.01）. Targetscan website predicted that autophagy related gene 5 （ATG5） was the potential target gene of miR-216b-5p；compared with control group，the expression level of ATG5 mRNA in the cells in miR-216b-5p group was significantly decreased（P<0.01）.The dual-luciferase assay proved that there was a targeting correlation between ATG5 and miR-216b-5p. Conclusion MiR-216b-5p can inhibit the proliferation， migration， and invasion and induce apoptosis of laryngeal cancer cells to exert a tumor suppressor effect， and its mechanism may be related to the targeted regulation of the expression level of ATG5.

Key words: Laryngeal neoplasms, Laryngeal squamous cell cancer, MiR-216b-5p, TU686 cells, Autophagy related gene 5

中图分类号:

R739.65

于宗男,崔颖. miR-216b-5p对喉癌TU686细胞增殖、迁移和侵袭的影响及其机制[J]. 吉林大学学报(医学版), 2023, 49(1): 116-121.

Zongnan YU,Ying CUI. Effect of miR-216b-5p on proliferation, migration and invasion of laryngeal cancer TU686 cells and its mechanism[J]. Journal of Jilin University(Medicine Edition), 2023, 49(1): 116-121.

图/表 6

图1

图2

图3

图4

图5

图6

参考文献 20

1	MARKOU K， CHRISTOFORIDOU A， KARASMANIS I， et al. Laryngeal cancer： epidemiological data from Νorthern Greece and review of the literature［J］. Hippokratia， 2013， 17（4）： 313-318.
2	LI Y S， YAN B R， WANG X， et al. ALKBH5-mediated m6A modification of lncRNA KCNQ1OT1 triggers the development of LSCC via upregulation of HOXA9［J］. J Cell Mol Med， 2022， 26（2）： 385-398.
3	JENCKEL F， KNECHT R. State of the art in the treatment of laryngeal cancer［J］. Anticancer Res， 2013， 33（11）： 4701-4710.
4	LU T X， ROTHENBERG M E. microRNA［J］. J Allergy Clin Immunol， 2018， 141（4）： 1202-1207.
5	NILSEN T W. Mechanisms of microRNA-mediated gene regulation in animal cells［J］. Trends Genet， 2007， 23（5）： 243-249.
6	PILLAI R S， BHATTACHARYYA S N， FILIPOWICZ W. Repression of protein synthesis by miRNAs： how many mechanisms？［J］. Trends Cell Biol， 2007， 17（3）： 118-126.
7	FILIPOWICZ W， BHATTACHARYYA S N， SONENBERG N. Mechanisms of post-transcriptional regulation by microRNAs： are the answers in sight？［J］. Nat Rev Genet， 2008， 9（2）： 102-114.
8	TAN J， JING Y Y， HAN L， et al. microRNA-203 inhibits invasion and induces apoptosis of laryngeal cancer cells via targeting LASP1［J］. Eur Rev Med Pharmacol Sci， 2018， 22（19）： 6350-6357.
9	ZHOU M， WANG Y， ZHANG C M， et al. microRNA-195-5p suppresses the proliferation， migration， invasion and epithelial-mesenchymal transition of laryngeal cancer cells in vitro by targeting E2F3［J］. Exp Ther Med， 2021， 22（4）： 1078.
10	MENBARI M N， RAHIMI K， AHMADI A， et al. miR-216b-5p inhibits cell proliferation in human breast cancer by down-regulating HDAC8 expression［J］. Life Sci， 2019， 237： 116945.
11	YOU Y， TAN J X， GONG Y， et al. microRNA-216b-5p functions as a tumor-suppressive RNA by targeting TPT1 in pancreatic cancer cells［J］. J Cancer， 2017， 8（14）： 2854-2865.
12	刘浩，穆兰，黄志伟，等. 喉鳞状细胞癌相关microRNA的筛选及功能鉴定［J］. 锦州医科大学学报， 2021， 42（2）： 40-44.
13	LEE R C， FEINBAUM R L， AMBROS V. The C. elegans heterochronic gene Lin-4 encodes small RNAs with antisense complementarity to Lin-14［J］. Cell， 1993， 75（5）： 843-854.
14	GRIFFITHS-JONES S， GROCOCK R J， VAN DONGEN S， et al. miRBase： microRNA sequences， targets and gene nomenclature［J］. Nucleic Acids Res， 2006， 34（Database issue）： D140-D144.
15	REDA EL SAYED S， CRISTANTE J， GUYON L， et al. microRNA therapeutics in cancer： current advances and challenges［J］.Cancers （Basel），2021，13（11）： 2680.
16	LIU W， LI X L， TAN X， et al. microRNA-204-3p inhibits metastasis of pancreatic cancer via downregulating MGAT1［J］. J BUON， 2021， 26（5）： 2149-2156.
17	HE S Z， WANG Q. microRNA-548c-5p inhibits the proliferation of breast cancer cells through regulating Wnt/β-catenin signaling pathway［J］. Eur Rev Med Pharmacol Sci， 2020， 24（7）： 3795-3804.
18	LU J， GETZ G， MISKA E A， et al. microRNA expression profiles classify human cancers［J］. Nature， 2005， 435（7043）： 834-838.
19	TRANG P， MEDINA P P， WIGGINS J F， et al. Regression of murine lung tumors by the let-7 microRNA［J］. Oncogene， 2010， 29（11）： 1580-1587.
20	KOTA J， CHIVUKULA R R， O’DONNELL K A，et al. Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model［J］. Cell， 2009， 137（6）： 1005-1017.

[1]	祝效鹏, 刘百龙, 郭亮, 刘慧, 历程, 刘敏, 董丽华. 喉部小细胞神经内分泌癌患者长期无病生存1例报告及文献复习[J]. 吉林大学学报(医学版), 2019, 45(02): 405-409.
[2]	战仕花, 王苹, 尹万忠, 祝威. 白藜芦醇对喉癌Hep-2细胞顺铂敏感性的增强作用及其机制[J]. 吉林大学学报(医学版), 2015, 41(02): 282-286.
[3]	王贺彬，汪雅芳，沈妙言，李娜，赵丽晶，滕博. siRNA沉默eIF4E诱导人喉癌Hep-2细胞凋亡及其机制[J]. 吉林大学学报(医学版), 2014, 40(01): 39-43.
[4]	尚静\|房宁\|滕思莹\|崔香艳\|汪欣. 喉鳞状细胞癌组织中Snail和E-cadherin的表达及其意义[J]. J4, 2012, 38(2): 315-319.
[5]	许燕飞\|冯青杰\|滕博\|赵婕\|马丽. 喉鳞状细胞癌组织中Galectin-3表达与Bcl-2、Mmp-2及K-ras表达的相关性分析[J]. J4, 2011, 37(6): 1116-1119.
[6]	李光宇\|姜晓丹\|孟粹达\|高鸽\|朱冬冬. 细胞黏附分子SLeX和CD24在喉鳞状细胞癌组织中的表达[J]. J4, 2011, 37(2): 304-307.
[7]	崔香艳, 汪欣, 陈玮伦, 于红, 黄可新, 祝威. Brg1在喉鳞状细胞癌组织中的表达及意义[J]. J4, 2010, 36(3): 546-549.
[8]	宋朝霞, 祝威, 李鹏, 刘冰. 抑癌基因PTEN单核苷酸多态性与喉癌的关系[J]. J4, 2009, 35(5): 918-922.
[9]	陈玮伦，李秋明，祝威，郭晓峰，崔航. 喉癌细胞周期和细胞凋亡的同步检测及意义[J]. J4, 2008, 34(5): 854-859.
[10]	张连芝，孙吉凤，王少华，王为方，杨柳，王宁，刘剑凯. 吲哚美辛对喉癌Hep-2细胞增殖与iNOS活性的影响[J]. J4, 2008, 34(2): 251-253.
[11]	许承弼，滕博，李长青，金春顺. 喉鳞状细胞癌中RASSF1A基因启动子区甲基化及蛋白表达[J]. J4, 2006, 32(2): 326-329.
[12]	徐海洋，路秀英，马婧，李晓明. 肿瘤坏死因子受体及其信号转导蛋白TRAF2在喉癌中的表达[J]. J4, 2006, 32(2): 322-325.
[13]	付仲鹰，张慰天，郭晓峰，全成实. 表皮黏钙素基因突变及蛋白表达异常与喉癌转移的关系[J]. J4, 2005, 31(5): 788-790.
[14]	施小茹，李晓明，王哲文，路秀英. survivin在喉癌组织中表达及其与细胞凋亡的关系[J]. J4, 2005, 31(5): 761-764.
[15]	付仲鹰，全成实，郭晓峰. 喉癌转移中黏附分子CD44v6蛋白表达和胞内环素α、β mRNA的表达[J]. J4, 2004, 30(6): 919-921.